Boxer Capital Management, LLC, by Aaron I Davis, Managing Member
@Boxer Capital, Llc
Latest period2024 - Q3ReportedManaged Assets$2.038BTotal holdings68
Assets growth rate7.32%Assets growth rate (2-Q avg)0.55%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Boxer Capital, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 68 positions.
Assets under management
The assets under management (AUM) of Boxer Capital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2.038B in assets, with a quarterly growth rate of 7.32% and a 2-quarter average growth rate of 0.55%. The portfolio is managed by Boxer Capital Management, LLC, by Aaron I Davis, Managing Member, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
RCKTRocket Pharmaceuticals Inc
| 1.33% | $27.078M 1.466M shares@ $18.48 avg price | |
RCUSArcus Biosciences Inc
| 1.21% | $24.498M 1.602M shares@ $15.29 avg price | |
TILInstil Bio Inc
| 1.18% | $23.932M 355,500 shares@ $67.32 avg price | New Position |
XENEXenon Pharmaceuticals Inc
| 1.16% | $23.622M 600,000 shares@ $39.37 avg price | |
IMVTImmunovant Inc
| 1.16% | $23.521M 825,000 shares@ $28.51 avg price | |
KYMRKymera Therapeutics Inc
| 1.05% | $21.299M 450,000 shares@ $47.33 avg price | New Position |
SYRESpyre Therapeutics Inc
| 1.01% | $20.483M 696,480 shares@ $29.42 avg price | |
KURAKura Oncology Inc
| 0.96% | $19.54M 1M shares@ $19.54 avg price | |
KALVKalvista Pharmaceuticals Inc
| 0.91% | $18.412M 1.59M shares@ $11.58 avg price | |
NKTXNkarta Inc
| 0.9% | $18.214M 4.03M shares@ $4.52 avg price | Decreased -28.13% |